Saturday 17 October 2026
Export NIVF’s income statement to Excel — free account
NewGenIvf Group Limited
NIVF Healthcare Medical Care Facilities
NewGenIvf Group Limited’s revenue for fiscal 2025 (year ended December 2025) was $4.7 million, down 13.0% from fiscal 2024. Dividend growth for five consecutive years; insiders bought in the last twelve months.
0.28
0.03
+12.00%
Follow NIVF
| Jun '26 | Dec '25 | Sep '25 | Jun '25 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
1.06 | 3.12 | 3.43 | 2.21 |
+3 more quarters Free account |
Net Debt/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
Debt/Assets |
0.00% | 12.52% | 13.78% | 23.17% | |
Debt/Equity |
0.00 | 0.16 | 0.17 | 0.39 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | — | |
Operating CF/Net income |
— | 0.00 | — | — | |
Capex/Depreciation |
— | (0.56) | — | — | |
Intangible Assets out of Total Assets |
0.59 | 0.65 | 0.68 | 0.39 | |
Free Cash Flow per Share |
— | 0.00 | — | — | |
Cash per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Shareholders Equity per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow |
— | (11.06) | — | — | |
Working Capital |
0.62 | 5.02 | 3.93 | 2.79 | |
Capital Expenditures |
— | (0.13) | — | — | |
Net Current Asset Value |
0.40 | 0.65 | (1.26) | (0.94) | |
| Other line items | |||||
Quick Ratio |
0.15 | 0.73 | 1.14 | 1.25 | |
Operating CF per Share |
— | 0.00 | — | — | |
Capex per Share |
— | 0.00 | — | — | |
Average Receivables |
0.87 | 0.66 | 1.90 | — | |
Average Payables |
1.09 | 0.48 | 0.45 | — | |
Average Inventory |
0.22 | 0.23 | 0.07 | — | |
Average Assets |
20.01 | 18.61 | 19.23 | — | |
Average Common Equity |
12.12 | 13.20 | 14.42 | — | |
Capex to Sales |
— | 0.00 | — | — |
Columns are period end dates · fundamentals updated 9 Oct 2026